CEO
Stella Diagnostics
(OTCMKTS: JMDP)
Joe Abdo has over a decade of experience in molecular oncology research, R&D and business development in both private and public biotechnology organizations. Dr. Abdo has won several awards for his research and has published over a dozen articles and a text book in the fields of molecular oncology, proteomics, genomics, immunotherapy and gastrointestinal diseases, placing advancements in patient care at the forefront of his work.
He earned a PhD in Clinical and Translational Science from Creighton University School of Medicine where he investigated biochemical mechanisms of Barrett’s-related esophageal adenocarcinoma. He also received a Master’s degree in Biotechnology from Georgetown University School of Medicine where he researched genomic and proteomic expression abnormalities in patients with gastro-intestinal diseases. Most recently, he was the Senior Director of Clinical and Translational Science at PolarityTE, MD Inc.